Nebivolol: impact on cardiac and endothelial function and clinical utility.
about
Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failureTherapeutic approach in the improvement of endothelial dysfunction: the current state of the artEffects of traditional Chinese medicine Xin-Ji-Er-Kang formula on 2K1C hypertensive rats: role of oxidative stress and endothelial dysfunctionCombined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension.ß-blocker timolol prevents arrhythmogenic Ca²⁺ release and normalizes Ca²⁺ and Zn²⁺ dyshomeostasis in hyperglycemic rat heart.Cardiovascular-related healthcare resource utilization and costs in patients with hypertension switching from metoprolol to nebivolol.Lack of β2 -adrenoceptors aggravates heart failure-induced skeletal muscle myopathy in miceEffect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertensionHypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivololAdrenoreceptors and nitric oxide in the cardiovascular system.A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk.Hypercholesterolemia and Hypertension: Two Sides of the Same Coin.Nebivolol Attenuates Neutrophil Lymphocyte Ratio: A Marker of Subclinical Inflammation in Hypertensive Patients.Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.Beta-blocker timolol alleviates hyperglycemia-induced cardiac damage via inhibition of endoplasmic reticulum stress.Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats.Nebivolol Ameliorates Hepatic Ischemia/Reperfusion Injury on Liver But Not on Distant Organs.Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.
P2860
Q26822825-6B05DD4E-75B3-4A63-87BB-2B4A835C43A1Q27027533-D4EA0DA5-3E51-496D-82B5-A821E9397C84Q34816253-189293C1-8F84-4750-9CD6-E84602FEBA28Q34886548-1BC3BA03-8A3D-4B34-8337-DF5708BA84D9Q34907705-4A13A234-B3F8-43C5-BF9D-94B07663B917Q35623864-B5EBA38C-BF49-431B-B7D6-1425B69C35CAQ35867936-6D5C8D70-2A56-4D19-BE90-EEE8F91F5C8CQ36072467-0D37E89F-DADC-4348-9AEE-85A04FD2A97AQ36982759-93D9E3CA-15F7-467E-81BE-BCB3F07A17EBQ38162217-0064E96B-1DF3-4365-8BE1-E8DAD1ABF4B3Q38433805-7BD4AC6D-226C-42B0-BB9D-C9D7811C810AQ38524257-F068DE33-43A2-423B-AE21-0CAC8013AB18Q38618940-CF53FC8A-A040-429D-8FED-3422B5A49771Q39157832-FE1A8577-C402-4183-BBD6-8290BF9CDB3CQ45338593-11D8F30E-C5BC-4239-AE89-8355C0E35DD0Q46824814-A0446BF9-6AB3-424E-940A-404FE6599EB1Q53367845-1C85D370-D00B-4CEC-94B7-CFEF419A7C0FQ54445753-79B7F741-678E-41B6-AEAF-6DC28B75A75E
P2860
Nebivolol: impact on cardiac and endothelial function and clinical utility.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nebivolol: impact on cardiac and endothelial function and clinical utility.
@ast
Nebivolol: impact on cardiac and endothelial function and clinical utility.
@en
type
label
Nebivolol: impact on cardiac and endothelial function and clinical utility.
@ast
Nebivolol: impact on cardiac and endothelial function and clinical utility.
@en
prefLabel
Nebivolol: impact on cardiac and endothelial function and clinical utility.
@ast
Nebivolol: impact on cardiac and endothelial function and clinical utility.
@en
P2093
P2860
P921
P356
P1476
Nebivolol: impact on cardiac and endothelial function and clinical utility
@en
P2093
Federico DiGennaro
Jorge Eduardo Toblli
Jorge Fernando Giani
P2860
P304
P356
10.2147/VHRM.S20669
P407
P577
2012-03-13T00:00:00Z